Presented in part at the 33rd Annual Meeting of the American Society for Bone and Mineral Research, September 16–20, 2011, San Diego, CA, USA (J Bone Miner Res. 2011;26 Suppl 1:S296, Abstract SU0185; http://www.asbmr.org/asset.axd=id=3a0b2165-3a2a-44b6-a73f-32462b40c96b&t=634490047148230000) and at the 50th Annual Meeting of the European Society for Pediatric Endocrinology, September 25–28, 2011, Glasgow, UK (Horm Res Paediatr. 2011;76 Suppl 2:63).
Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy†
Article first published online: 15 JAN 2013
Copyright © 2013 American Society for Bone and Mineral Research
Journal of Bone and Mineral Research
Volume 28, Issue 2, pages 419–430, February 2013
How to Cite
Otero, J. E., Gottesman, G. S., McAlister, W. H., Mumm, S., Madson, K. L., Kiffer-Moreira, T., Sheen, C., Millán, J. L., Ericson, K. L. and Whyte, M. P. (2013), Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy. J Bone Miner Res, 28: 419–430. doi: 10.1002/jbmr.1752
- Issue published online: 15 JAN 2013
- Article first published online: 15 JAN 2013
- Accepted manuscript online: 12 SEP 2012 09:07AM EST
- Manuscript Accepted: 24 AUG 2012
- Manuscript Revised: 9 JUL 2012
- Manuscript Received: 24 OCT 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.